ERGOSUM

ERGOSUM IPA MOD v1.12.64 (Damage – Defense Multiplier) iOS

CROOZ Blockchain Lab,inc.

22 November 2024 (7 months ago)

App Name ERGOSUM
Latest Version v1.12.64
Last Updated 22 November 2024
Requires Android 12.0
Category
Size 601 MB
MOD Info Damage Multiplier - Defense Multiplier
4/5 Rating (54974)
ERGOSUM IPA MOD (Damage – Defense Multiplier) iOS is an innovative mobile RPG that combines traditional gameplay elements with blockchain technology, offering players a unique “play-to-earn” experience. Set in a visually stunning fantasy world, the game explores themes of destiny and forbidden knowledge through its captivating storyline. Players embark on quests, explore dungeons, and battle enemies while collecting valuable NFTs (Non-Fungible Tokens) that can be traded in the game’s marketplace. Developed by CROOZ Blockchain Lab, ERGOSUM stands out for its accessibility, allowing both crypto enthusiasts and newcomers to participate in blockchain gaming without extensive prior knowledge. With its blend of engaging RPG mechanics, beautiful graphics, and the potential for real-world value creation, ERGOSUM offers a fresh and exciting gaming experience that bridges the gap between traditional mobile gaming and the emerging world of GameFi. Download ERGOSUM IPA

How to Download And Install ERGOSUM IPA on iPhone iPad without computer?

1- Download Scarlet or Trollstore or Esign To install ERGOSUM IPA
2- Go to settings > Profiles & devices management > trust on developer.
3- Download ERGOSUM IPA on iPhone iPad And Send to Scarlet or Trollstore or Esign

How to Install ERGOSUM IPA with Sideloadly?

1- Download Sideloadly And open for install ERGOSUM
2- Connect your ios device to PC. Drag the ERGOSUM IPA file into Sideloadly
3- Before install ERGOSUM Provide Apple ID and Password And verified It
4- Click Start To install ERGOSUM
5- Go to settings > Profiles & devices management > trust ERGOSUM on developer.
6- And iOS 16 Go To Privacy & Security Open Developer Mode

Leave a comment

No comments. Write your first comment.

Comments are closed.